Diabetes is a chronic disease that affects millions of individuals worldwide. According to the World Health Organization, approximately 422 million people live with diabetes, and this number is likely to rise in the coming years.

While there are currently many treatments available to manage diabetes, a new procedure may provide an alternative that offers improved, long-lasting results.

What is the New Procedure?

The new diabetes procedure is called “duodenal mucosal resurfacing” or DMTR. It is a minimally invasive procedure that uses heat to reshape the inner lining of the small intestine.

The goal of the procedure is to improve the body’s ability to produce insulin, the hormone that helps regulate blood sugar levels.

The DMTR procedure involves using a device known as a hot balloon catheter. This catheter is inserted through the mouth and guided down into the small intestine.

Once in place, the balloon is inflated with hot water, which causes the lining of the small intestine to change shape.

Doctors believe that this reshaping of the lining of the small intestine can improve insulin sensitivity. Insulin sensitivity refers to how well the body uses insulin to regulate blood sugar levels.

When the body is insulin resistant, it cannot effectively use insulin, leading to high blood sugar levels. By improving insulin sensitivity, the DMTR procedure may help control blood sugar levels in individuals with diabetes.

What are the Benefits of DMTR?

The DMTR procedure offers several benefits over traditional diabetes treatments. One of the most significant benefits is its long-lasting results.

In a recent study published in the medical journal, Diabetes Care, researchers found that DMTR could help control blood sugar levels for up to two years.

Furthermore, DMTR is a minimally invasive procedure that does not require surgery or long hospital stays. The procedure can be performed on an outpatient basis, and most individuals can return to their normal activities within 24 hours.

Another benefit of DMTR is its safety. The procedure has been shown to be safe and well-tolerated in clinical trials. There have been no serious adverse events reported in any of the studies conducted to date.

Who is a Candidate for DMTR?

The DMTR procedure is still in the clinical trial stages, and it is not yet widely available. However, the procedure shows promise for individuals with type 2 diabetes who are struggling to manage their blood sugar levels with current treatments.

The procedure may be particularly beneficial for individuals who are overweight or obese. Studies have shown that weight loss can improve insulin sensitivity, and the DMTR procedure may help facilitate weight loss by improving insulin sensitivity.

If you are interested in receiving the DMTR procedure, consult with your healthcare provider to determine if you are a candidate.

Conclusion

The DMTR procedure offers a promising new approach for managing diabetes. Its long-lasting results, minimally invasive nature, and safety make it an attractive option for individuals struggling with diabetes.

While the procedure is not yet widely available, ongoing clinical trials offer hope that it will soon be accessible to those who need it.